Atlas Trials

Effects of Psilocybin in Post-Treatment Lyme Disease

Clinical trial NCT05305105 · COMPLETED

Trial details

NCT number
NCT05305105
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Post-Treatment Lyme DiseaseChronic Lyme DiseaseLyme Disease, Chronic
Start date
2022-07-01
Primary completion
2024-10-26
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.